SPDR S&P Biotech ETF
708 hedge funds and large institutions have $7.19B invested in SPDR S&P Biotech ETF in 2023 Q1 according to their latest regulatory filings, with 75 funds opening new positions, 227 increasing their positions, 236 reducing their positions, and 95 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
708
Holders Change
-34
Holders Change %
-4.58%
% of All Funds
11.33%
Holding in Top 10
23
Holding in Top 10 Change
-8
Holding in Top 10 Change %
-25.81%
% of All Funds
0.37%
New
75
Increased
227
Reduced
236
Closed
95
Calls
$1.15B
Puts
$1.7B
Net Calls
-$543M
Net Calls Change
-$894M
Top Buyers
| 1 |
JPMorgan Chase & Co
New York
|
$574M |
| 2 |
Barclays
London,
United Kingdom
|
$314M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
$946M |
| 4 |
Jane Street
New York
|
$117M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$99.5M |
